Practical Perspectives on Clinical Controversies in MS
A Case-Based Approach
Music City Center, Nashville, Tennessee
Thursday, May 31, 2018 @ 4:30 pm
    Overview

    Brief clinical vignettes introduce 3 patients with multiple sclerosis (MS) -- one with clinically isolated syndrome, another with highly active MS, and a third who is planning a pregnancy -- followed by expert faculty members' in-depth discussion of these cases. These scenarios highlight the need for highly effective therapy, which Dr Leist will discuss further in the final segment of the program.

    Speakers
    • Stephen Krieger, MD
      Moderator
      Associate Professor of Neurology; Director, Neurology Residency Program, Icahn School of Medicine at Mount Sinai, New York, New York
    • Anne H. Cross, MD
      Panelist
      Professor of Neurology, Manny and Rosalyn Rosenthal - Dr. John Trotter; MS Chair in Neuroimmunology, Washington University School of Medicine, Saint Louis, Missouri
    • Maria Houtchens, MD, MMS
      Panelist
      Assistant Professor of Neurology; Director, Women's Health Program, Partners MS Center, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts
    • Thomas P. Leist, MD, PhD
      Panelist
      Professor of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania
    Program Thursday, May 31, 2018
    • 4:30 PM
    • Dinner and Registration
    • 5:00 PM
    • Welcome, Instructions, and Introductions
      Stephen Krieger, MD
    • 5:05 PM
    • Treatment Decisions in Clinically Isolated Syndrome: Impact of the 2017 Updated McDonald Criteria
      Stephen Krieger, MD
    • 5:25 PM
    • Management Considerations for Highly Active RRMS
      Anne H. Cross, MD
    • 5:45 PM
    • Pregnancy in MS: Strategies for Care
      Maria Houtchens, MD, MMS
    • 6:05 PM
    • Review of High-Efficacy Therapies in Development for MS
      Thomas P. Leist, MD, PhD
    • 6:20 PM
    • Questions & Answers
    Meet Your MS Patients
    Target Audience
    This activity is intended for neurologists, primary care physicians, nurses, and other healthcare professionals who care for patients with multiple sclerosis (MS).
    Goal Statement
    The goal of this program is to highlight the selection of appropriate therapy for patients with clinically isolated syndrome and those with highly active MS.
    Learning Objectives
    Upon completion of this activity, participants will:
    • Have increased knowledge regarding the
      • Clinical data for new and emerging disease-modifying therapies in MS
    • Have greater competence related to
      • Development of an individualized treatment plan for a patient with MS who is interested in becoming pregnant
      • Selection of an appropriate therapy for the management of patients with highly active relapsing-remitting MS (RRMS)
    Disclaimer
    This symposium is neither sponsored nor endorsed by the Consortium of Multiple Sclerosis Centers.
    Accreditation Statement
    In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
    Credits Available
    • 1.50
    • For Physicians
    Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    For Nurses: Awarded 1.50 contact hour(s) of continuing nursing education for RNs and APNs; 1.50 contact hours are in the area of pharmacology.
    Nashville, Tennessee
    Music City Center
    Ballroom A
    201 Fifth Avenue South
    Supporter
    Supported by an independent educational grant from
    EMD Serono